Close Menu

A proposal is making the rounds of the NCAA's Division I teams to test all athletes for sickle cell trait, according to an article in the New York Times. But the measure is being disputed by some groups, such as the Sickle Cell Disease Association of America, that say the results could be used to discriminate against athletes who test positive for the disease, and that changing training practices would be enough to lower their risk of death.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novamax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.